Cypris Medical, a company that develops, manufactures, and markets medical devices for plastic surgeons, won “Best of Hot Topics” for its Xact technology, a lasting minimally invasive face and neck lifting suturing device from the 2018 American Society for Aesthetic Plastic Surgery (ASAPS) annual meeting in New York.

Cypris CEO Dan Holton presented Xact (cleared by the FDA in 2017) at the Aesthetics Innovation Summit just prior to the annual meeting.

“Our core technology, Xact, replaces two of the oldest technologies in surgery, the 100-year-old needle holder and the 70-year-old forceps,” said Holton. “The first target market is facial rejuvenation, including face and neck lifting. The unmet need is the lack of treatments available for patients who have exhausted benefits from facial injectables (‘filler fatigue’) but are not ready to make the jump to a full face lift.”

The Xact is projected to be available to surgeons in Q4 of 2018. 

For more information, visit our medtech case study to learn more about the system's design and engineering process, or visit cyprismed.com.

UPDATE JULY 23, 2019

Cyrpis Medical announced the commercial launch of their Xact device. This is the only minimally invasive option for effective and lasting treatment of gravitational descent in the face and neck. You can read more about the 2019 launch in their press release.